Sci Simple

New Science Research Articles Everyday

# Health Sciences # Infectious Diseases (except HIV/AIDS)

The Growing Threat of Antimicrobial Resistance

Antimicrobial resistance is rising globally, complicating treatment of infections.

Kate S Baker, Y. L. Tam, P. M. De Silva, C. R. Barker, R. Li, L. Santos, G. Batisti Biffignandi, C. E. Chong, L. C. E. Mason, S. Nair, P. Ribeca, S. C. Bayliss, C. Jenkins, S. Bakshi, J. P. J. Hall, L. Cowley

― 6 min read


Antimicrobial Resistance: Antimicrobial Resistance: A Global Crisis posing major public health challenges. Drug-resistant infections are rising,
Table of Contents

Antimicrobial Resistance (AMR) is a serious global health issue. It occurs when bacteria no longer respond to medicines that once worked against them. This situation makes infections harder to treat and can lead to longer hospital stays, higher medical costs, and increased risk of death. Recent studies show that specific types of bacteria are becoming more resistant to treatments, especially in certain areas of the world.

The Rise of AMR Bacterial Types

One notable example is a type of bacteria called S. Typhimurium sequence type 313 (ST313), which is common in Africa, especially in severe disease cases. Another example is a type of E. Coli known as sequence type 131 (ST131) that has spread worldwide. There is also a resistant type of K. pneumoniae (sequence type 258) that poses a significant threat. Moreover, a particular type of Shigella, named Lineage III S. sonnei, shows many forms resistant to drugs. When these resistant bacteria spread, it becomes difficult to treat infections effectively.

In an ideal world, researchers would use the vast amounts of genomic data available to create systems that can predict and monitor AMR. This would help identify bacteria that are likely to become resistant, allowing for timely intervention. However, for this to happen, we need to know how these bacteria develop resistance.

Understanding Shigella and Its Spread

Shigella is a pathogen known for causing severe diarrhea and has become more frequent as a sexually transmitted infection among men who have sex with men (MSM) over the last few decades. In places like the United States and the United Kingdom, researchers found that there are closely related strains of Shigella circulating among MSM who have not traveled recently. These strains are often linked to sexual transmission networks (STN).

Studies indicate that there are many types of Shigella in circulation, and these types face significant pressure from antimicrobial treatments. This pressure leads to the acquisition of resistance genes and other changes that help the bacteria survive in high-treatment environments. Alarmingly, these resistant strains spread quickly around the world and share their resistance traits with other bacteria.

Identifying Genetic Factors in Shigella

In recent research, scientists investigated 15 different Shigella lineages from approximately 3,745 isolates collected in the UK. They aimed to find genetic features linked to the development of AMR. Using advanced methods, they constructed a detailed family tree of these bacteria and identified factors that might contribute to AMR trends.

One key finding was a genetic element called metG, which encodes a protein important for bacteria's ability to survive under stress from antibiotics. The metG gene was often found on a specific mobile genetic element called pWPMR2, which can move between different bacteria. This gene variation was notably higher among the Shigella isolates that were linked to STN.

The Role of metG in Antimicrobial Resistance

Research showed that the metG gene could help bacteria cope with antibiotics, particularly third-generation cephalosporins. When scientists conducted genetic analyses, they discovered that bacteria carrying the metG gene on pWPMR2 had a lot of mutations compared to those without it. These mutations might allow the bacteria to survive even when faced with high levels of antibiotics.

To investigate further, researchers created two types of E. coli strains: one with the standard metG gene and another with the mutated version found on the pWPMR2 element. They found that the mutated metG gene helped E. coli grow better in the presence of certain antibiotics, suggesting that this gene could provide an advantage in resisting treatment.

The Spread of pWPMR2

The team also looked into how the pWPMR2 element spreads among various bacteria. They found similarities between pWPMR2 and other genetic elements in different bacteria, including those involved in serious outbreaks of E. coli and Shigella. This mobile genetic element was identified in bacteria from multiple countries, indicating it might be common in resistant strains globally.

Findings on the Connection Between metG and AMR

During experiments, researchers found that the pWPMR2 element promotes the spread of metG in other bacteria. Their tracking of AMR traits suggested that pWPMR2 had been present in bacterial populations for some time but went unnoticed until now.

The research highlighted two important points. First, scientists need to broaden their focus beyond traditional markers of AMR, as there are other traits that contribute to a bacteria’s ability to thrive and spread. Second, there is a need for more adaptable surveillance systems to quickly detect and address changes in bacteria's genetic makeup that might lead to AMR.

The Impact of AMR on Public Health

The emergence of AMR in bacteria like Shigella poses a growing public health threat. Infections that were once easily treatable are becoming increasingly difficult to manage. The spread of mobile genetic elements, such as pWPMR2, facilitates this resistance, making it crucial to monitor how these elements move between bacteria.

The urgent concern is that the mechanisms that allow bacteria to survive under antibiotic pressure may lead to the development of strains that are resistant to multiple drugs. The rise in resistant infections can result in severe complications for patients, with longer hospital stays and increased healthcare costs.

A Real-time Example of AMR Evolution

Recently, a new outbreak of extensively drug-resistant S. sonnei was reported in England. This outbreak involved cases linked to the pWPMR2 element, reaffirming the role of this genetic factor in the spread of AMR bacteria. It is essential to recognize that as the bacteria evolve, they can develop traits that make them more difficult to control.

Conclusion

The findings underline the importance of monitoring not just well-known AMR genes but also genetic elements like pWPMR2 that carry traits influencing bacterial behavior and survival. As bacterial resistance continues to evolve, public health systems must adapt to track and mitigate the risks posed by these resistant strains. Enhanced data collection, broader focus on various bacterial traits, and agile responses to changes in genetic make-up are critical in fighting the increasing threat of AMR.

The current understanding of AMR is that it is not just a result of antibiotic misuse but also an evolutionary response of bacteria. Continued research is vital to uncover the complexities behind AMR and to develop strategies to combat the rising tide of resistant infections.

Original Source

Title: Phage-plasmid borne methionine tRNA ligase mediates epidemiologically relevant antimicrobial persistence

Abstract: Antimicrobial resistance (AMR) is a global public health crisis with few options for control. As such early identification of emerging bacterial strains capable of rapidly evolving AMR is key. Although antimicrobial tolerance and persistence are precursor phenotypes for AMR, little evidence exists to support their importance in real-world settings. Here we used bacterial genome wide association on national genomic surveillance data of the diarrhoeal pathogen Shigella sonnei (n=3745) to agnostically identify common genetic signatures among lineages convergently evolving toward AMR (n=15). This revealed an association of an AMR trajectory with a multi- and highly variable second copy of metG, borne by a phage-plasmid we called pWPMR2. Further analyses revealed that pWPMR2 was present across clinically relevant enteric pathogens globally, including past and contemporary outbreaks, and that the additional-metG mechanism was present across multiple bacterial phyla. Functional microbiology, experimental evolution, and single-cell physiology studies confirmed that the expression of auxiliary metG, particularly the mutated version on pWPMR2, created a sub population of persister cells predisposed to survival in, and evolving resistance against, third generation cephalosporins. Thus, we demonstrate a novel mechanism of auxiliary metG carriage that predisposes bacteria to AMR with real world impacts. Furthermore, our approach is a timely example of using genomic epidemiology to rapidly guide functional microbiology studies in the era of routine genomic surveillance, and also highlights several deficiencies in current AMR surveillance practices.

Authors: Kate S Baker, Y. L. Tam, P. M. De Silva, C. R. Barker, R. Li, L. Santos, G. Batisti Biffignandi, C. E. Chong, L. C. E. Mason, S. Nair, P. Ribeca, S. C. Bayliss, C. Jenkins, S. Bakshi, J. P. J. Hall, L. Cowley

Last Update: 2024-12-18 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.10.27.24316207

Source PDF: https://www.medrxiv.org/content/10.1101/2024.10.27.24316207.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles